4.6 Article

Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort

期刊

PLOS ONE
卷 17, 期 9, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0273896

关键词

-

资金

  1. Malaysia Ministry of Higher Education Fundamental Research Grant Scheme (FRGS) [600-IRMI/FRGS 5/3 (067/2019]
  2. Malaysia Ministry of Higher Education Long Term Research Grant Scheme [RMI/ST/LRGS5/3 (2/2011]
  3. Universiti Teknologi MARA MITRA Grant [600-IRMI/MYRA 5/3/MITRA (003/20170)-1]
  4. Malaysia Ministry of Higher Education Fundamental Research Grant Scheme (FRGS) [600-IRMI/FRGS 5/3 (067/2019]

向作者/读者索取更多资源

This study aimed to determine the prevalence of clinically diagnosed familial hypercholesterolemia (FH) among angiogram-proven premature coronary artery disease (PCAD) patients in the Asian population. The study found that potential FH is common among PCAD patients and contributes greatly to PCAD. The presence of FH, diabetes, hypertension, obesity, and family history of PCAD are independent predictors of PCAD.
BackgroundFamilial hypercholesterolaemia (FH) patients have elevated levels of low-density lipoprotein cholesterol, rendering them at high risk of premature coronary artery disease (PCAD). However, the FH prevalence among angiogram-proven PCAD (AP-PCAD) patients and their status of coronary risk factors (CRFs) have not been reported in the Asian population. ObjectivesThis study aimed to (1) determine the prevalence of clinically diagnosed FH among AP-PCAD patients, (2) compare CRFs between AP-PCAD patients with control groups, and (3) identify the independent predictors of PCAD. MethodsAP-PCAD patients and FH patients without PCAD were recruited from Cardiology and Specialist Lipid Clinics. Subjects were divided into AP-PCAD with FH (G1), AP-PCAD without FH (G2), FH without PCAD (G3) and normal controls (G4). Medical records were collected from the clinic database and standardised questionnaires. FH was clinically diagnosed using Dutch Lipid Clinic Network Criteria. ResultsA total of 572 subjects were recruited (males:86.4%; mean +/- SD age: 55.6 +/- 8.5years). The prevalence of Definite, Potential and All FH among AP-PCAD patients were 6%(19/319), 16% (51/319) and 45.5% (145/319) respectively. G1 had higher central obesity, family history of PCAD and family history of hypercholesterolaemia compared to other groups. Among all subjects, diabetes [OR(95% CI): 4.7(2.9,7.7)], hypertension [OR(95% CI): 14.1(7.8,25.6)], FH [OR(95% CI): 2.9(1.5,5.5)] and Potential (Definite and Probable) FH [OR(95% CI): 4.5(2.1,9.6)] were independent predictors for PCAD. Among FH patients, family history of PCAD [OR(95% CI): 3.0(1.4,6.3)] and Definite FH [OR(95% CI): 7.1(1.9,27.4)] were independent predictors for PCAD. ConclusionPotential FH is common among AP-PCAD patients and contributes greatly to the AP-PCAD. FH-PCAD subjects have greater proportions of various risk factors compared to other groups. Presence of FH, diabetes, hypertension, obesity and family history of PCAD are independent predictors of PCAD. FH with PCAD is in very-high-risk category, hence, early management of modifiable CRFs in these patients are warranted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据